Fine Foods H1 FY26 turns to net loss of €2.4 million; revenue slips 3.1% to €124.8 million

Reuters2026/09/08 12:08

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Fine Foods & Pharmaceuticals NTM posted H1 2026 revenue of €124.8 million, down 3.1% from H1 2025.
Pharma BU revenue rose 12% to €46.6 million, lifted by the fully operational Brembate site and Sofar consolidation.
IFRS net result turned to a loss of €2.4 million from a profit a year earlier, hit by a €4 million non-cash impairment.
Adjusted EBITDA fell to €15.2 million, down from €21.6 million; margin narrowed 4.6 percentage points to 12.2%.
Net financial position widened to €98 million from €47.9 million at end-2025, reflecting Sofar acquisition spending and capex.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fine Foods & Pharmaceuticals NTM S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 20094_171394_2026_oneinfo.pdf), on September 08, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Fine Foods H1 FY26 turns to net loss of €2.4 million; revenue slips 3.1% to €124.8 million

You may also like

Crypto prices